Search

Your search keyword '"Lowe, Helen L."' showing total 30 results

Search Constraints

Start Over You searched for: Author "Lowe, Helen L." Remove constraint Author: "Lowe, Helen L."
30 results on '"Lowe, Helen L."'

Search Results

1. PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer

2. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

3. Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies

4. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

5. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

6. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

7. Body composition and lung cancer-associated cachexia in TRACERx

8. The evolution of non-small cell lung cancer metastases in TRACERx

9. The evolution of lung cancer and impact of subclonal selection in TRACERx

10. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

11. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

12. Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission

13. PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer

14. Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

15. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

16. Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

17. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

18. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

19. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

21. Evidence for different mechanisms of ‘unhooking’ for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples

22. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

23. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies (Preprint)

24. Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T Cells and synergizes with PD-1 Blockade to eradicate established tumors

25. Erratum: Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

26. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

27. Tracking the Evolution of Non–Small-Cell Lung Cancer

28. A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer

29. Evidence for different mechanisms of ‘unhooking’ for melphalan and cisplatin-induced DNA interstrand cross-links in vitroand in clinical acquired resistant tumour samples

Catalog

Books, media, physical & digital resources